Online citations, reference lists, and bibliographies.
← Back to Search

A Systematic Review Of Lung-sparing Extirpative Surgery For Pleural Mesothelioma

Elaine S Teh, F. Fiorentino, Carol H Tan, T. Treasure
Published 2011 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Summary Objectives There is a resurgence of interest in lung-sparing extirpative surgery for malignant pleural mesothelioma with recent reports of better survival and fewer adverse consequences than with extrapleural pneumonectomy. However, these operations are not well-characterized and to offer evidence-based clinical recommendations and to plan future trials a summary of what is already known is required. Design A formal literature search was performed and all recovered titles were sequentially sifted by title, abstract and full-text reading according to prespecified criteria. Papers were selected if they contained data relevant to the area of enquiry. Quantitative synthesis and textual analysis, appropriate to the material, were performed. Setting Follow-up studies of patients undergoing surgery for malignant pleural mesothelioma in specialist thoracic or cardiothoracic units. Participants Among the operated patients described in these papers, a total of 1270 patients had undergone lung-sparing surgery for mesothelioma. Results There were no randomized trials or other forms of controlled studies. From 464 titles, 26 papers contained sufficient data on 1270 patients to be included in the systematic review. Operative descriptions for all series were extracted and tabulated and variation was found in the nature of surgery within and between series, and the degree of detail with which it was described. There was more operative detail in recent papers. All available numerical data were extracted, tabulated and summarized using quantitative methods. The average survival at 1, 2, 3, 4 and 5 years was 51%, 26%, 16%, 11% and 9%, respectively. There were no data on patients’ performance status, symptomatic change, or other patient reported outcomes. Conclusions In the absence of any form of control data, no conclusions can be drawn concerning survival differences or symptomatic benefits attributable to surgery. As mesothelioma surgery is restricted to a selected minority of patients who often have multiple therapies, future research will require controlled studies with explicit definitions of the clinical and surgical intent.
This paper references
Four-Modality Therapy in Malignant Pleural Mesothelioma: A Phase II Study
M. Lucchi (2007)
Continuing increase in mesothelioma mortality in Britain
J. Peto (1995)
Polyhematoporphyrin-mediated photodynamic therapy and decortication in palliation of malignant pleural mesothelioma: a clinical pilot study.
V. Matzi (2004)
Diagnostic and therapeutic strategy in malignant pleural mesothelioma.
D. Branscheid (1991)
Intrapleural chemotherapy for patients with incompletely resected malignant mesothelioma: The ucla experience
J. D. Lee (1995)
The role of video assisted thoracoscopic pleurectomy/decortication in the therapeutic management of malignant pleural mesothelioma.
A. Nakas (2008)
Prognostic Factors in the Treatment of Malignant Pleural Mesothelioma at a Large Tertiary Referral Center
R. Flores (2007)
Pleurectomy/decortication plus chemotherapy: outcomes of 40 cases of malignant pleural mesothelioma.
F. Colaut (2004)
Malignant pleural mesothelioma: A survival study
J. Harvey (1990)
Case-control study between extrapleural pneumonectomy and radical pleurectomy/decortication for pathological N2 malignant pleural mesothelioma.
A. Martin-Ucar (2007)
[Malignant pleural mesothelioma].
Q. Kong (1983)
Optimal management of malignant mesothelioma after subtotal pleurectomy: Revisiting the role of intrapleural chemotherapy and postoperative radiation
E. Sauter (1995)
The diagnosis, therapy and prognosis of diffuse malignant mesothelioma.
R. Achatzy (1989)
Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma.
T. T. Lee (2002)
Obtaining an upper estimate of the survival benefit associated with surgery for mesothelioma.
M. Utley (2010)
Surgery Followed by Intracavitary plus Systemic Chemotherapy in Malignant Pleural Mesothelioma
M. Colleoni (1996)
Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients.
M. Law (1984)
Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers.
A. Alberts (1988)
Malignant pleural mesothelioma. Extrapleural pneumonectomy and pleurectomy.
K. Allen (1994)
Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma.
G. Ceresoli (2001)
The European mesothelioma epidemic
J. Peto (1999)
Treatment of mesothelioma in Bloemfontein, South Africa.
W. de Vries (2003)
Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.
R. Flores (2008)
Ten traps for the unwary in surgical series: a case study in mesothelioma reports.
T. Treasure (2007)
Malignant Pleural Mesothelioma: Surgical Management in 285 Patients
P. Bejarano (2009)
Long-term results of intrathoracic chemohyperthermia (ITCH) for the treatment of pleural malignancies
O. Monneuse (2003)
Radical surgery for malignant pleural mesothelioma: results and prognosis.
M. Okada (2008)
Occupational, domestic and environmental mesothelioma risks in the British population: a case–control study
C. Rake (2009)
Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma
A. Scherpereel (2009)
Pleurectomy for mesothelioma
R. Brancatisano (1991)
Open lung-sparing surgery for malignant pleural mesothelioma: the benefits of a radical approach within multimodality therapy.
A. Nakas (2008)
Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.
D. Sugarbaker (1999)
The management of malignant pleural mesothelioma; single centre experience in 10 years.
T. Aziz (2002)
The Treatment of Malignant Mesothelioma of the Pleura: Review of a 5‐Year Experience, With Special Reference to Radiotherapy
D. Ball (1990)
Mesothelioma--VATS biopsy and lung mobilization improves diagnosis and palliation.
M. Grossebner (1999)
Elevated Serum Cytokine Levels in Mesothelioma Patients Who Have Undergone Pleurectomy or Extrapleural Pneumonectomy and Adjuvant Intraoperative Photodynamic Therapy¶
S. S. Yom (2003)
R Rintoul (2010)
Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma
H. Pass (2006)
Malignant pleural mesothelioma: outcome of limited surgical management.
P. G. Phillips (2003)
Management of Malignant Mesothelioma by Decortication and Adjunct Phototherapy
C. P. Clarke (2006)

This paper is referenced by
Malignant pleural mesothelioma: current and future perspectives.
Konstantinos Porpodis (2013)
Mesothelioma and Radical Surgery 2 (MARS 2): protocol for a multicentre randomised trial comparing (extended) pleurectomy decortication versus no (extended) pleurectomy decortication for patients with malignant pleural mesothelioma
E. Lim (2020)
Is less also better? A single-institution experience on treatment of early stage Malignant Pleural Mesothelioma.
P. Bertoglio (2017)
Malignant pleural mesothelioma.
D. Ettinger (2012)
Lung, Chest Wall, Pleura, and Mediastinum
J. Putnam (2012)
Extrapleural pneumonectomy in malignant pleural mesothelioma
O. Rena (2011)
NCCN Guidelines Insights: Malignant Pleural Mesothelioma, Version 3.2016.
D. Ettinger (2016)
Survival by Histologic Subtype of Malignant Pleural Mesothelioma and the Impact of Surgical Resection on Overall Survival
V. Verma (2018)
Long-term survival after lung-sparing total pleurectomy for locally advanced (International Mesothelioma Interest Group Stage T3-T4) non-sarcomatoid malignant pleural mesothelioma.
A. Nakas (2012)
Mesothelioma and Radical Surgery (MARS): a randomised controlled trial of extrapleural pneumonectomy for malignant pleural mesothelioma
T. Treasure (2011)
Mesothelioma: a review.
F. Mott (2012)
Extrapleural pneumonectomy for early stage malignant pleural mesothelioma: a harmful procedure.
O. Rena (2012)
Pleurectomy–decortication in malignant pleural mesothelioma: are different surgical techniques associated with different outcomes? Results from a multicentre study†
G. Marulli (2017)
Massive localized malignant pleural mesothelioma (LMPM): manifestations on computed tomography in 6 cases.
Weigen Yao (2015)
Current issues in malignant pleural mesothelioma evaluation and management.
J. Ai (2014)
Modern management of malignant pleural mesothelioma
S. Patel (2016)
Trimodality treatment in malignant pleural mesothelioma - Ordeal or real deal?
N. Mummudi (2020)
Trimodality Treatment in Malignant Pleural Mesothelioma: An Ordeal or The Real Deal?
N. Mummudi (2020)
Investigational Approaches for Mesothelioma
V. Surmont (2011)
Modern Surgical Techniques in Malignant Pleural Mesothelioma
Y. Kahya (2016)
Surgery in mesothelioma--where do we go after MARS?
B. Hiddinga (2013)
Surgery for mesothelioma: the evidence base and a pragmatic approach to surgical treatment
V. Pai (2017)
Surgery and Multimodality Treatment in Malignant Pleural Mesothelioma
F. Rea (2019)
Surgery for malignant pleural mesothelioma: an international guidelines review.
S. Ricciardi (2018)
Diaphragm and lung–preserving surgery with hyperthermic chemotherapy for malignant pleural mesothelioma: A 10‐year experience
M. Ambrogi (2018)
Early mesothelioma revisited
S. Hasegawa (2011)
Malignant pleural mesothelioma and the Society of Thoracic Surgeons Database: an analysis of surgical morbidity and mortality.
B. Burt (2014)
Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial
R. Rintoul (2014)
Surgery in the treatment of malignant pleural mesothelioma: recruitment into trials should be the default position
A. Datta (2013)
Scuola di Dottorato in Scienze Fisiopatologiche e neuropsicobiologiche e assistenziali del ciclo della vita - Ciclo XXVIII
Roberto Weinstein (2015)
Emerging therapies for malignant pleural mesothelioma
J. Quispel-Janssen (2012)
Does Surgery Improve Survival of Patients with Malignant Pleural Mesothelioma?: A Multicenter Retrospective Analysis of 1365 Consecutive Patients
P. Bovolato (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar